Phio Pharmaceuticals Corp. (PHIO)

1.26 -0.03 (-2.33%) USD  |  NASDAQ  |  Apr 20, 16:00
1.26 0.00 (0.00%) After-Hours: 17:54
More

Phio Pharmaceuticals SG&A Expense (Quarterly) : 1.057M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Tonix Pharmaceuticals Holding Corp. 35.68M
Jaguar Health, Inc. 7.164M
MetaVia, Inc. 1.805M
Seastar Medical Holding Corp. 1.224M
Jupiter Neurosciences, Inc. 2.783M